Augmedix Inc reports results for the quarter ended in January - Earnings Summary

Augmedix

13/08/2024 02:16

* Augmedix Inc  AUGX.OQ  reported a quarterly adjusted loss
of 13
cents​​ per share for the quarter ended in January, lower than
the same quarter last year, when the company reported EPS of -12
cents.  The mean expectation of three analysts for the quarter
was for a loss of 13 cents per share. Wall Street expected
results to range from -15 cents to -12 cents per share.
    * Revenue rose 26.8% to $13.66 million from a year ago;
analysts
expected $13.64 million. 
    * Augmedix Inc's reported EPS for the quarter was a loss
of 16
cents​.
    * The company reported a quarterly loss of $8.36 million.
    * Augmedix Inc shares had risen by 158.0% this quarter and
lost 61.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 4.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the business
support
services peer group is also "buy"

Wall Street's median 12-month price target for Augmedix Inc is
$2.93 
This summary was machine generated from LSEG data August 13 at
01:15 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.13          -0.13          Met
 Mar. 31 2024      -0.13          -0.12          Beat
 Dec. 31 2023      -0.10          -0.09          Beat
 Sep. 30 2023      -0.12          -0.10          Beat